TP53 and malignant colon neoplasm: A study conducted by Buzzai et al. examined the effect of the anti-diabetic drug metformin on tumor growth in the presence of metformin in the colon cancer cell lines HCT116 p53+/+ and HCT116p53−/−, which were isogenic colon cancer cell lines.